Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

radioimmunoconjugate

(RAY-dee-oh-IH-myoo-noh-KON-jih-gut)

A radioactive substance that carries radiation directly to cancer cells. A radioimmunoconjugate is made by attaching a radioactive molecule to an immune substance, such as a monoclonal antibody, that can bind to cancer cells. This may help kill cancer cells without harming normal cells. Radioimmunoconjugates may also be used with imaging to help find cancer cells in the body.

radioimmunoconjugate

Search NCI's Dictionary of Cancer Terms